EUVIMEDEUVIMED entdecken
Crossref

The Hemoglobin–Albumin–Lymphocyte–Platelet Score and Diabetic Neuropathy in Patients with Type 2 Diabetes Mellitus

Aysun Şeker iD, Seydahmet Akin, Doğa Coşkun

Experimental and Clinical Endocrinology & Diabetes · 2026-10 · 134 (10) · 338-343

DOI: 10.1055/a-2890-1089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, online erschienen am 17.07.2026. Verfasst von Aysun Şeker und 2 weiteren Autor:innen. Beteiligte Einrichtung: Kartal Dr Lutfi Kirdar City Hospital, Department of Internal Medicine, Istanbul, Turkey, Istanbul. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Neuropathies, Blood Platelets, Serum Albumin. Die Arbeit nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic neuropathy is a common microvascular complication of type 2 diabetes mellitus associated with chronic inflammation and metabolic dysregulation. The hemoglobin–albumin–lymphocyte–platelet score is a composite index reflecting nutritional and inflammatory status, but its association with diabetic neuropathy remains insufficiently characterized. In this retrospective cross-sectional study, 212 patients with type 2 diabetes mellitus were evaluated. Diabetic neuropathy was defined using electrophysiological criteria. Multivariable logistic regression analysis was performed to assess the association between the hemoglobin–albumin–lymphocyte–platelet score and diabetic neuropathy after adjustment for age, sex, diabetes duration, body mass index, and glycated hemoglobin. The hemoglobin–albumin–lymphocyte–platelet score was analyzed as a continuous variable (per 0.1-unit increase) and in quartiles. Receiver operating characteristic curve analysis was used to evaluate model discrimination. Diabetic neuropathy was present in 45.2% of patients. The hemoglobin–albumin–lymphocyte–platelet levels were significantly lower in patients with diabetic neuropathy compared to those without diabetic neuropathy (0.36±0.18 vs. 0.72±0.39, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Diabetic NeuropathiesBlood PlateletsSerum AlbuminLymphocytesGlycated HemoglobinHumansFemaleMaleCross-Sectional StudiesMiddle AgedRetrospective StudiesAged

Substanzen

Serum AlbuminGlycated Hemoglobin

Autor:innen und Institutionen

  • Kartal Dr Lutfi Kirdar City Hospital, Department of Internal Medicine, Istanbul, Turkey, Istanbul.
  • Kartal Dr Lutfi Kirdar City Hospital, Department of Neurology, Istanbul, Turkey, Istanbul.

ORCID-Profile: Aysun Şeker

Zitieren

APA

Şeker, A., Akin, S., & Coşkun, D. (2026). The Hemoglobin–Albumin–Lymphocyte–Platelet Score and Diabetic Neuropathy in Patients with Type 2 Diabetes Mellitus. Experimental and Clinical Endocrinology & Diabetes, 134(10), 338-343. https://doi.org/10.1055/a-2890-1089

Vancouver

Şeker A, Akin S, Coşkun D. The Hemoglobin–Albumin–Lymphocyte–Platelet Score and Diabetic Neuropathy in Patients with Type 2 Diabetes Mellitus. Experimental and Clinical Endocrinology & Diabetes. 2026;134(10):338-343. doi:10.1055/a-2890-1089

BibTeX
@article{eker2026,
  author = {Şeker, Aysun and Akin, Seydahmet and Coşkun, Doğa},
  title = {The Hemoglobin–Albumin–Lymphocyte–Platelet Score and Diabetic Neuropathy in Patients with Type 2 Diabetes Mellitus},
  journal = {Experimental and Clinical Endocrinology & Diabetes},
  year = {2026},
  volume = {134},
  number = {10},
  pages = {338--343},
  doi = {10.1055/a-2890-1089}
}
Kostenlos starten →